Komipharm International Co (XKRX:041960) EPS (Basic) : ₩189.00 (TTM As of Dec. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Komipharm International Co EPS (Basic)?

Komipharm International Co's basic earnings per share (Basic EPS) for the three months ended in Dec. 2024 was ₩11.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was ₩189.00.

Komipharm International Co's EPS (Diluted) for the three months ended in Dec. 2024 was ₩11.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ₩189.00.

Komipharm International Co's EPS without NRI for the three months ended in Dec. 2024 was ₩10.67. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was 86.01.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Komipharm International Co's highest 3-Year average EPS without NRI Growth Rate was 49.90% per year. The lowest was -81.20% per year. And the median was 4.35% per year.

Komipharm International Co EPS (Basic) Historical Data

The historical data trend for Komipharm International Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Komipharm International Co EPS (Basic) Chart

Komipharm International Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

Get a 7-Day Free Trial

-39.98

-63.60

-84.49

-57.00

188.00

Komipharm International Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EPS (Basic)	Get a 7-Day Free Trial															-12.00	11.00	73.00	94.00	11.00

Komipharm International Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Komipharm International Co's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(13113.267	-	0)	/	69.751
	=	188.00

Komipharm International Co's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(761.449	-	0)	/	69.653
	=	10.93

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩189.00

Komipharm International Co (XKRX:041960) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Komipharm International Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Komipharm International Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Komipharm International Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Komipharm International Co Ltd (XKRX:041960) » Definitions » EPS (Basic)

Traded in Other Exchanges

N/A

Address

1236-6 Jungwang-Dong, Sihung, Gyeonggi, KOR, 429-450

Website

http://www.komilab.co.kr

Komipharm International Co Ltd is involved in the healthcare sector based in Korea. Its core business includes development and manufacture of veterinary vaccines and veterinary pharmaceuticals. The company produces its products under two divisions: veterinary vaccines such as total vaccines of respiratory disease for swine, vaccines of anthrax disease and black leg for cattle. The other division is made up of veterinary pharmaceuticals such as antibiotics, nutrients, disinfectants and others, which are used to treat pneumonia, pasteurellosis, enteritis, mastitis and swine erysipelas.

Komipharm International Co Headlines

No Headlines